John B. Sanfilippo & Son, Inc. JBSS 深 沪
已收盘 05-15 16:00:00 美东时间
74.91
+0.160
+0.21%
华盛通- 最 高75.335
- 今 开74.87
- 成交量 11.22万股
- 最 低 73.90
- 昨 收 74.75
- 总市值 8.76亿
- 52周最高 84.89
- 市盈率 静 14.90
- 换手率 0.96%
- 52周最低 56.39
- 委 比 96.15%
- 总股本 1168.96万
- 历史最高 118.16
- 量 比 1.04
- 振 幅 1.92%
- 历史最低 -35.12
- 每 手 1
- 风险率 8.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Transcript: John B Sanfilippo & Son Q3 2026 Earnings Conference Call
On Thursday, John B Sanfilippo & Son (NASDAQ:JBSS) discussed third-quarter ...
04-30 22:43
John B Sanfilippo & Son Q3 EPS $1.43 Beats $1.16 Estimate, Sales $281.779M Beat $260.825M Estimate
John B Sanfilippo & Son (NASDAQ:JBSS) reported quarterly earnings of $1.43 per share which beat the analyst consensus estimate of $1.16 by 23.28 percent. This is a 16.86 percent decrease over earnings of $1.72 per share
04-30 04:12
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
John B. Sanfilippo & Son Declares Special Dividend Of $1.50/Share
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special Dividend") of $1.50 per share on all issued and
03-31 04:11
美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
BWS Financial Maintains Buy on John B Sanfilippo & Son, Maintains $109 Price Target
BWS Financial analyst Hamed Khorsand maintains John B Sanfilippo & Son (NASDAQ:JBSS) with a Buy and maintains $109 price target.
02-03 04:39
Earnings Scheduled For January 29, 2026
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
John B Sanfilippo & Son's Earnings Outlook
John B Sanfilippo & Son (NASDAQ:JBSS) will release its quarterly earnings r...
01-29 05:02
Adecoagro's Earnings: A Preview
Adecoagro (NYSE:AGRO) is set to give its latest quarterly earnings report on Tu...
2025-11-10 22:03
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
